(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.



Fig. 6. Mutations in the Sce1 gene lead to ovarian defects. (A-E) Sce1 mosaic follicles stained with DAPI (A,B), anti-Fas III (A'',B',C,C',E,E'), or anti-{alpha}-Spectrin (D,D') antibodies. Mutant clones for Sce1 are detected by the absence of GFP (A',B',C,D,E, green). (A-A'') Compound follicle (A, arrows point to oocyte nuclei) bearing several Sce1 clones marked by the absence of GFP staining (A') and exhibiting two pairs of polar cells at the anterior and posterior poles (A''). (B-) Mosaic Sce1/Sce+ germarium. Sce1 mutant prefollicular cells do not migrate correctly arround germline cysts (B', bracket). Arrowhead points to an abnormal interfollicular stalk with Sce1 cells on another focal plane. (C,D) Interfollicular stalks are very long and all cells express Fas III (C,C') as well as {alpha}-Spectrin (D,D') at high levels compared with adjacent follicle cells. Empty arrowhead (C) points to one Sce1 cell (four other Sce1 cells are present in this stalk). (E-E') Mosaic Sce1/Sce+ follicle. Sce1 follicular cells strongly express Fas III protein compared with adjacent Sce+ cells.